Work

Supplementary Table S1 from A Phase II Study of Docetaxel and Pembrolizumab plus Interleukin 12 Gene Therapy in Nonmetastatic, Anthracycline-Refractory Triple-Negative Breast Cancer (INTEGRAL)

Year: 2026

Type: supplementary-materials

Abstract: SUPPLEMENTARY Table 1: Stopping Rules

DOI: 10.1158/1078-0432.32711114

Authors: Polly Niravath, Ivonne Uzair, Kai Sun, Hanh Mai, Jian Guan, Mailin Li, Jenying Deng, Wei Qian, Jianying Zhou, Liliana Guzman, Kelsey Banaglorioso, Rabia Hashmani, Sunil Mathur, Jenny Chang

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W7165000126

Cites:

Cited by:

Related to: 10